multiplex diagnostics | GenomeWeb

multiplex diagnostics

The firm will adapt multiplex panels for prognosis of septic shock patients to its array-based portable diagnostic platform.

The new platform, called Fusion, is an addition to the Panther system and will run qPCR assays with three "mini panels" currently in the works.

The companies will use their respective technologies to develop multiplex molecular diagnostic panels for laboratory testing.

The firm priced each share at $.47, and plans to use the funding for general corporate purposes and working capital.

The scientists believe they have created a more accurate way to detect mutations that often lead to hereditary colorectal cancer.

The San Diego diagnostics firm's technology is designed for rapid, multiplexed, blood-based testing in a physician's office setting.

The special conditions of MDx use in the pediatric market may also present advantages in patient satisfaction metrics, a BioFire representative said. 

The researchers are also developing the method in tandem with a more extensive pathogen profiling diagnostic platform from Swedish startup Q-linea.

NEW YORK (GenomeWeb News) – MRC Technology today announced a collaboration with Renishaw Diagnostics to identify and develop clinical diagnostic tests for infectious diseases.

NEW YORK (GenomeWeb News) – Genalyte today announced it has inked distribution deals for its Maverick Detection System covering parts of Europe.
The system, which analyzes multiple antibodies and other proteins, also received the CE Mark for research use in Europe.

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.